Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Nyaradzo M, Mgodi"'
Autor:
Adlight Dandadzi, Alinda M. Young, Petina Musara, Mary Kate Shapley-Quinn, Doreen Kemigisha, Prisca Mutero, Nyaradzo M. Mgodi, Juliane Etima, Alexandra A. Minnis
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Multipurpose prevention technologies (MPTs) are products capable of simultaneously addressing multiple sexual and reproductive health needs such as unwanted pregnancy, STIs including HIV-1, and other reproductive tract infections.
Externí odkaz:
https://doaj.org/article/dfc4b5312c13440390a024ea2723d562
Autor:
Yunda Huang, Lily Zhang, Shelly Karuna, Philip Andrew, Michal Juraska, Joshua A. Weiner, Heather Angier, Evgenii Morgan, Yasmin Azzam, Edith Swann, Srilatha Edupuganti, Nyaradzo M. Mgodi, Margaret E. Ackerman, Deborah Donnell, Lucio Gama, Peter L. Anderson, Richard A. Koup, John Hural, Myron S. Cohen, Lawrence Corey, M. Juliana McElrath, Peter B. Gilbert, Maria P. Lemos
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-19 (2023)
Abstract Broadly neutralizing monoclonal antibodies (mAbs) are being developed for HIV-1 prevention. Hence, these mAbs and licensed oral pre-exposure prophylaxis (PrEP) (tenofovir-emtricitabine) can be concomitantly administered in clinical trials. I
Externí odkaz:
https://doaj.org/article/1573cc55a90c4367a36a05f7470f768e
Autor:
Zoe Moodie, Erica Andersen-Nissen, Nicole Grunenberg, One B Dintwe, Faatima Laher Omar, Jia J Kee, Linda-Gail Bekker, Fatima Laher, Nivashnee Naicker, Ilesh Jani, Nyaradzo M Mgodi, Portia Hunidzarira, Modulakgota Sebe, Maurine D Miner, Laura Polakowski, Shelly Ramirez, Michelle Nebergall, Simbarashe Takuva, Lerato Sikhosana, Jack Heptinstall, Kelly E Seaton, Stephen De Rosa, Carlos A Diazgranados, Marguerite Koutsoukos, Olivier Van Der Meeren, Susan W Barnett, Niranjan Kanesa-Thasan, James G Kublin, Georgia D Tomaras, M Juliana McElrath, Lawrence Corey, Kathryn Mngadi, Paul Goepfert, HVTN 107 Protocol Team
Publikováno v:
PLoS Medicine, Vol 21, Iss 3, p e1004360 (2024)
BackgroundAdjuvants are widely used to enhance and/or direct vaccine-induced immune responses yet rarely evaluated head-to-head. Our trial directly compared immune responses elicited by MF59 versus alum adjuvants in the RV144-like HIV vaccine regimen
Externí odkaz:
https://doaj.org/article/909a7c021d8247d2955cca75b0f8a084
Autor:
Adlight Dandadzi, Sanyukta Mathur, Lisa B Haddad, Thesla Palanee-Phillips, Barbara A Friedland, Nyaradzo M Mgodi, Marlena G Plagianos, Irene V Bruce, Maud Lansiaux, Caroline Murombedzi, Petina Musara, Krishnaveni Reddy, Nkosiphile Ndlovu, Sihle K Zulu, Lerato R Shale, Brady Zieman
Publikováno v:
BMJ Open, Vol 14, Iss 3 (2024)
Introduction Oral pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention method; however, uptake and persistence have been low among southern African women. A dual prevention pill (DPP) that combines PrEP with oral contraception (OC) ma
Externí odkaz:
https://doaj.org/article/d091ce6552644105bf77fa53e4e3749c
Publikováno v:
Frontiers in Reproductive Health, Vol 5 (2023)
The global burden of HIV remains unacceptably high despite significant progress made in HIV treatment and prevention. There is an urgent need to scale up the comprehensive HIV prevention strategies that include pre-exposure prophylaxis (PrEP). Oral P
Externí odkaz:
https://doaj.org/article/798550697c1f445dbcd671f1917a996b
Autor:
Nyaradzo M. Mgodi, Grant Murewanhema, Enos Moyo, Chesterfield Samba, Godfrey Musuka, Tafadzwa Dzinamarira, Joelle M. Brown
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss S2, Pp n/a-n/a (2023)
Abstract Introduction The burden of HIV in sub‐Saharan Africa (SSA) remains unacceptably high, and disproportionately affects girls and women. While the introduction of oral HIV pre‐exposure prophylaxis (PrEP) in 2012 revolutionized HIV preventio
Externí odkaz:
https://doaj.org/article/7a865295d31c4c4cb6ea49f12281f05b
Autor:
Gui Liu, Nelly R Mugo, Cara Bayer, Darcy White Rao, Maricianah Onono, Nyaradzo M Mgodi, Zvavahera M Chirenje, Betty W Njoroge, Nicholas Tan, Elizabeth A Bukusi, Ruanne V Barnabas
Publikováno v:
EClinicalMedicine, Vol 45, Iss , Pp 101306- (2022)
Summary: Background: Cervical cancer incidence is high in Kenya due to HIV and limited access to cancer prevention services. Human papillomavirus (HPV) has been shown to increase HIV acquisition; however, the potential impact of HPV vaccination on HI
Externí odkaz:
https://doaj.org/article/3240ae906c464e98a7b6e31728808dbe
Autor:
Craig A Magaret, David C Benkeser, Brian D Williamson, Bhavesh R Borate, Lindsay N Carpp, Ivelin S Georgiev, Ian Setliff, Adam S Dingens, Noah Simon, Marco Carone, Christopher Simpkins, David Montefiori, Galit Alter, Wen-Han Yu, Michal Juraska, Paul T Edlefsen, Shelly Karuna, Nyaradzo M Mgodi, Srilatha Edugupanti, Peter B Gilbert
Publikováno v:
PLoS Computational Biology, Vol 15, Iss 4, p e1006952 (2019)
The broadly neutralizing antibody (bnAb) VRC01 is being evaluated for its efficacy to prevent HIV-1 infection in the Antibody Mediated Prevention (AMP) trials. A secondary objective of AMP utilizes sieve analysis to investigate how VRC01 prevention e
Externí odkaz:
https://doaj.org/article/3019dcf47cb24cdaa070a934c89ffc44
Autor:
Alexandra M. Minnis, Juliane Etima, Petina Musara, Erica N. Browne, Prisca Mutero, Doreen Kemigisha, Nyaradzo M. Mgodi, Clemensia Nakabiito, Mary Kate Shapley-Quinn, Marie C. D. Stoner, Miriam Hartmann, Nicole Macagna, Jeanna Piper, Ariane van der Straten
Publikováno v:
AIDS and Behavior. 26:3848-3861
End-user input early in biomedical product development may optimize design to support high uptake and adherence. We interviewed 400 couples (800 total participants) in Uganda and Zimbabwe to assess their preferences for multipurpose prevention techno
Autor:
Petina Musara, Miriam Hartmann, Julia H Ryan, Krishnaveni Reddy, Joseph Ggita, Prisca Mutero, Nicole Macagna, Frank Taulo, Nyaradzo M Mgodi, Jeanna Piper, Ariane van der Straten
Publikováno v:
African Journal of AIDS Research; Vol. 21 No. 4 (2022); 354-363
We examined men’s influence on women’s interest in biomedical HIV prevention during pregnancy and breastfeeding through structured questionnaires and focus group discussions with currently or recently pregnant and breastfeeding (P/BF) women (n =